Elad Arad is an experienced Executive Coordinator and Operations Manager at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP since April 2022, previously serving as Personal Business Assistant to the CEO at Freshmarket Ltd., where responsibilities included managing strategic projects and enhancing performance through research and analytical methodologies. Prior to this, Elad held various roles in project management and business development, notably at PwC Israel, where legal and operational aspects of companies under liquidation were managed. Additional experience includes consulting at M.R.A Investments Ltd. and training officers in the IDF Spokesperson's Unit, coupled with comprehensive educational credentials including an MBA from IE Business School and dual Bachelor's degrees in Business Management and Law from Reichman University.
This person is not in any teams
This person is not in any offices
Finnegan, Henderson, Farabow, Garrett & Dunner
2 followers
Finnegan is a true full-service IP firm handling patent, trademark, copyright, and trade secret law, with experts in every technology. Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is a true full-service IP firm with experts in every area of IP and every technology. A comprehensive approach to clients’ IP needs and Finnegan’s mega-boutique size underpins their year-to-year, decade-to-decade preeminence in IP litigation across all industries and tribunals. From offices in the United States, Asia, and Europe, Finnegan continues to be one of the world’s largest firms focusing on intellectual property, practicing all aspects of patent law, trademark law, copyright law, and trade secret law, representing clients on IP issues relating to U.S. and European patent and trademark law, international trade, portfolio management, the Internet, cybersecurity, e-commerce, government contracts, antitrust and unfair competition. Finnegan offers full-service IP legal experience and technical expertise in virtually every industry and technology, including biotechnology, pharmaceuticals, biologics and biosimilars, chemicals, electronic devices and components, computers and software, financial services and business systems, artificial intelligence (AI) and machine learning (ML), digital health, nanotechnology, automotive, aerospace and aviation, industrial manufacturing, consumer products, media, food and beverage, medical devices, clean energy and renewables, robotics, sports and fitness, textiles, and 3D printing.